Target intelligence / Profile preview

MYO16 antisense RNA 2 (MYO16-AS2)

Target
MYO16-AS2
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

MYO16 antisense RNA 2 (MYO16-AS2) is a long non-coding RNA locus in the human genome. It is transcribed antisense to the protein-coding MYO16 gene, but does not encode a protein. There is currently no experimental evidence for a functional role of this lncRNA or its involvement in any known biological processes or diseases. MYO16-AS2 is not considered a direct therapeutic target, enzyme, transporter, transcription factor, or receptor. No common alternative names or abbreviations other than MYO16-AS2 have been identified[1]. Clarification: - The MYO16-AS2 gene should not be confused with *MYO16* (myosin XVI), which encodes a protein implicated in neuronal development and disease[2][3]. *MYO16* is a distinct entity with a broader functional literature, while *MYO16-AS2* is only annotated as a non-coding RNA transcript with no current evidence for a direct therapeutic or diagnostic role[1]. - There is no evidence of drugs or direct molecular targeting involving MYO16-AS2. Summary: MYO16-AS2 is a non-coding RNA gene, not a druggable target, receptor, or enzyme, and currently lacks evidence for a biological or disease-associated function[1].

Beyond the preview

Go deeper on MYO16 antisense RNA 2 (MYO16-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MYO16 antisense RNA 2 (MYO16-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call